Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
(2013) In Journal of Clinical Oncology 31(25). p.3091-3091- Abstract
- To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and/or BRCA2 mutation carriers.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/4006117
- author
- Phillips, Kelly-Anne
; Milne, Roger L
; Rookus, Matti A
; Daly, Mary B
; Antoniou, Antonis C
; Peock, Susan
; Frost, Debra
; Easton, Douglas F
; Ellis, Steve
; Friedlander, Michael L
; Buys, Saundra S
; Andrieu, Nadine
; Noguès, Catherine
; Stoppa-Lyonnet, Dominique
; Bonadona, Valérie
; Pujol, Pascal
; McLachlan, Sue Anne
; John, Esther M
; Hooning, Maartje J
; Seynaeve, Caroline
; Tollenaar, Rob A E M
; Goldgar, David E
; Terry, Mary Beth
; Caldes, Trinidad
; Weideman, Prue C
; Andrulis, Irene L
; Singer, Christian F
; Birch, Kate
; Simard, Jacques
; Southey, Melissa C
; Olsson, Håkan
LU
; Jakubowska, Anna
; Olah, Edith
; Gerdes, Anne-Marie
; Foretova, Lenka
and Hopper, John L
(Less) - organization
- publishing date
- 2013
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Oncology
- volume
- 31
- issue
- 25
- pages
- 3091 - 3091
- publisher
- American Society of Clinical Oncology
- external identifiers
-
- pmid:23918944
- wos:000330540600010
- scopus:84886448607
- pmid:23918944
- ISSN
- 1527-7755
- DOI
- 10.1200/JCO.2012.47.8313
- language
- English
- LU publication?
- yes
- id
- 1ae7e63f-7bb8-446e-868a-fdf2ae07d808 (old id 4006117)
- alternative location
- http://www.ncbi.nlm.nih.gov/pubmed/23918944?dopt=Abstract
- date added to LUP
- 2016-04-01 11:16:39
- date last changed
- 2022-02-18 01:28:36
@article{1ae7e63f-7bb8-446e-868a-fdf2ae07d808,
abstract = {{To determine whether adjuvant tamoxifen treatment for breast cancer (BC) is associated with reduced contralateral breast cancer (CBC) risk for BRCA1 and/or BRCA2 mutation carriers.}},
author = {{Phillips, Kelly-Anne and Milne, Roger L and Rookus, Matti A and Daly, Mary B and Antoniou, Antonis C and Peock, Susan and Frost, Debra and Easton, Douglas F and Ellis, Steve and Friedlander, Michael L and Buys, Saundra S and Andrieu, Nadine and Noguès, Catherine and Stoppa-Lyonnet, Dominique and Bonadona, Valérie and Pujol, Pascal and McLachlan, Sue Anne and John, Esther M and Hooning, Maartje J and Seynaeve, Caroline and Tollenaar, Rob A E M and Goldgar, David E and Terry, Mary Beth and Caldes, Trinidad and Weideman, Prue C and Andrulis, Irene L and Singer, Christian F and Birch, Kate and Simard, Jacques and Southey, Melissa C and Olsson, Håkan and Jakubowska, Anna and Olah, Edith and Gerdes, Anne-Marie and Foretova, Lenka and Hopper, John L}},
issn = {{1527-7755}},
language = {{eng}},
number = {{25}},
pages = {{3091--3091}},
publisher = {{American Society of Clinical Oncology}},
series = {{Journal of Clinical Oncology}},
title = {{Tamoxifen and Risk of Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.}},
url = {{http://dx.doi.org/10.1200/JCO.2012.47.8313}},
doi = {{10.1200/JCO.2012.47.8313}},
volume = {{31}},
year = {{2013}},
}